Pancreatitis in a child with acute lymphoblastic leukemia after Erwinia asparaginase: Evaluation of ultrasonography and computerized tomography as diagnostic tools

Pancreatitis in a child with acute lymphoblastic leukemia after Erwinia asparaginase: Evaluation of ultrasonography and computerized tomography as diagnostic tools

Show other versions (1)

Bibliographic Details
Main Authors:	Fatih Mehmet Azık, Gonca Kılıç
Format:	Article
Language:	English
Published:	Galenos Publishing House 2010-12-01
Series:	Turkish Journal of Hematology
Online Access:	http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-98698

Similar Items

Pancreatitis in a child with acute lymphoblastic leukemia after Erwinia asparaginase: Evaluation of ultrasonography and computerized tomography as diagnostic tools
by: Fatih Mehmet Azık, et al.
Published: (2010-12-01)

Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemia
by: Tong Lin, et al.
Published: (2023-05-01)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Soulaimane M'harzi, et al.
Published: (2022-01-01)

Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Aziza Elouali, et al.
Published: (2023-01-01)

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
by: Dominique Bollino, et al.
Published: (2022-12-01)

Hypertriglyceridemia with pancreatitis, a complication of l-asparaginase therapy in acute lymphoblastic leukemia, managed by therapeutic plasma exchange
by: Sourav Chowdhury, et al.
Published: (2023-01-01)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
by: Wafa Chenbah, et al.
Published: (2023-08-01)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
by: Madalina-Petronela Schmidt, et al.
Published: (2021-09-01)

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol
by: Jian Wang, et al.
Published: (2023-12-01)

l‑Asparaginase from Solanum lycopersicum as a Nutraceutical for Acute Lymphoblastic Leukemia
by: Sarina P. Khabade, et al.
Published: (2024-01-01)

Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia
by: Soumika Sengupta, et al.
Published: (2024-05-01)

Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach
by: Adesh Baral, et al.
Published: (2021-09-01)

Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia.
by: Eden, O, et al.
Published: (1990)

Unilateral Exudative Retinal Detachment as the Sole Presentation of Relapsing Acute Lymphoblastic Leukemia
by: Fatih Mehmet Azık, et al.
Published: (2012-05-01)

Monitoring asparaginase activity to improve the management of patients with acute lymphoblastic leukemia: Experience in one center
by: Marina García Morin, et al.
Published: (2024-01-01)

Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic Leukemia
by: Shawn H. R. Lee, et al.
Published: (2023-03-01)

Peer Review of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach“
by: Ariz Mohammad
Published: (2021-09-01)

P331: T-CELL RECEPTOR REPERTOIRE DIVERSITY AND L-ASPARAGINASE HYPERSENSITIVITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
by: S. Lee, et al.
Published: (2022-06-01)

Peer Review of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach“
by: Navneetha Hardikar
Published: (2021-09-01)

Peer Review of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach”
Published: (2021-09-01)

Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
by: Cristina Díaz-Barriga, et al.
Published: (2021-04-01)

Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line
by: Iris Munhoz Costa, et al.
Published: (2023-07-01)

A study of the adverse drug reactions of L-asparaginase in newly diagnosed children with acute lymphoblastic leukemia
by: Harshada Uchil, et al.
Published: (2017-01-01)

Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross‐sectional nationwide study in Spain
by: Álvaro Lassaletta, et al.
Published: (2023-02-01)

Asparaginase-Induced Acute Necrotizing Pancreatitis Resulting in Chronic Pancreatitis and Pseudocyst in an Adult with Acute Lymphocytic Leukemia
by: Randy Adiwinata, et al.
Published: (2023-04-01)

Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024-03-01)

Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases
by: Judit Müller, et al.
Published: (2023-07-01)

Authors’ Response to Peer Reviews of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach”
by: Adesh Baral, et al.
Published: (2021-09-01)

Monitoring of the treatment with L-asparaginase in children with acute lymphoblastic leukemia – focus on silent inactivation and its influence on the treatment outcome
by: Malgorzata Czogala, et al.
Published: (2023-01-01)

L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study
by: Amanda Cabral dosSantos, et al.
Published: (2022-08-01)

Vascular invasion in pancreatic cancer: evaluation of endoscopic ultrasonography, computed tomography, ultrasonography, and angiography
by: JL Frossard, et al.
Published: (2007-05-01)

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
by: Maria Agustina Perusini, et al.
Published: (2024-12-01)

PB1735: ONLINE CME PROGRAM IMPROVED CLINICIANS’ ABILITY TO MANAGE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH ASPARAGINASE-BASED THERAPIES
by: Sarah Elizabeth Bomba, et al.
Published: (2023-08-01)

Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment
by: Carmelo Rizzari, et al.
Published: (2014-09-01)

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)
by: F. Ravandi, et al.
Published: (2022-06-01)

Leukemia cutis: An unusual presentation of acute lymphoblastic leukemia in a child
by: Xia Jiang, et al.
Published: (2015-01-01)

Predicting Factors for Pancreatic Malignancy with Computed Tomography and Endoscopic Ultrasonography in Chronic Pancreatitis
by: Jian-Han Lai, et al.
Published: (2022-04-01)

Wernicke's Encephalopathy in a Child with Acute Lymphoblastic Leukemia
by: Hande Kızılocak, et al.
Published: (2017-03-01)

Hemiparesis and aphasia in a child with acute lymphoblastic leukemia
by: Sumeet G Dua, et al.
Published: (2011-01-01)

PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
by: Chiara Vernarecci, et al.
Published: (2023-08-01)